9th Oct 2006 12:13
Skyepharma PLC09 October 2006 For immediate release 9 October, 2006 SkyePharma PLC SkyePharma Appoints Company Secretary LONDON, ENGLAND, 9 October, 2006 -- SkyePharma PLC (LSE: SKP; Nasdaq: SKYE)today announces that it has appointed John Murphy as Company Secretary. John is a lawyer with extensive experience in legal and company secretarialroles in listed pharmaceutical and biotechnology companies including Medeva,Celltech and Pharmagene. John joined SkyePharma on 1st March this year asGeneral Counsel and will be combining both roles in the Company. For further information please contact: SkyePharma PLC +44 207 491 1777Frank Condella, Chief Executive OfficerKen Cunningham, Chief Operating OfficerSandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000Tim Anderson / Mark Court / Rebecca Skye Dietrich The Trout Group +1 617 583 1308Seth Lewis About SkyePharma SkyePharma PLC develops pharmaceutical products benefiting from world-leadingdrug delivery technologies that provide easier-to-use and more effective drugformulations. There are now twelve approved products incorporating SkyePharma'stechnologies in the areas of oral, injectable, inhaled and topical delivery,supported by advanced solubilisation capabilities. For more information, visitwww.skyepharma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L